Page last updated: 2024-10-23

bethanechol and Respiratory Tract Diseases

bethanechol has been researched along with Respiratory Tract Diseases in 1 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liao, YSJ1
Collins, EN1
Guevara, MV1
Schurmann, V1
Atanasova, KR1
Bravo, L1
Sponchiado, M1
Hoegger, MJ1
Reznikov, LR1

Other Studies

1 other study available for bethanechol and Respiratory Tract Diseases

ArticleYear
Airway cholinergic history modifies mucus secretion properties to subsequent cholinergic challenge in diminished chloride and bicarbonate conditions.
    Experimental physiology, 2020, Volume: 105, Issue:10

    Topics: Airway Resistance; Animals; Bethanechol; Bicarbonates; Biological Transport; Chlorides; Cholinergic

2020